Phytosterols Industry is expected to witness over 9% CAGR between 2021 and 2027, supported by rising occurrence of various diseases such as diabetes, obesity, and cardiovascular diseases.

The United States' phytosterols market from pharmaceutical annual consumption is set to surpass 4 kilotons by 2024, driven by increasing incidences, such as cardiovascular diseases and cancer, on account of climate dynamics.